Postnatal outcome in neonates with severe Rhesus c compared to Rhesus D hemolytic disease

Transfusion

Volumn 53, Issue 7, 2013, Pages 1580-1585

  Rath, Mirjam E A ^a   Smits Wintjens, Vivianne E H J ^a   Lindenburg, Irene T M ^a   Folman, Claudia C ^a   Brand, Anneke ^a   Van Kamp, Inge L ^a   Oepkes, Dick ^a   Walther, Frans J ^a   Lopriore, Enrico ^a  

^a not available

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS C ANTIBODY; RHESUS D ANTIBODY;

ARTICLE; COMPARATIVE STUDY; EXCHANGE BLOOD TRANSFUSION; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INTRAUTERINE BLOOD TRANSFUSION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN HEMOLYTIC DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHOTOTHERAPY; POSTNATAL CARE; RETROSPECTIVE STUDY;

EID: 84880198255     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03937.x     Document Type: Article

References (24)

1. Spong CY, Porter AE, Queenan JT,. Management of isoimmunization in the presence of multiple maternal antibodies. Am J Obstet Gynecol 2001; 185: 481-484.
2. Guidelines for blood grouping and red cell antibody testing during pregnancy. British Committee for Standards in Haematology, Blood Transfusion. Task Force Transfus Med 1996; 6: 71-74.
3. ACOG. Practice Bulletin No. 75: management of alloimmunization during pregnancy. Obstet Gynecol 2006; 108: 457-464.
4. Engelfriet CP, Ouwehand WH,. ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies. Baillieres Clin Haematol 1990; 3: 321-337.
5. Engelfriet CP, Overbeeke MA, Dooren MC, Ouwehand WH, von dem Borne AE,. Bioassays to determine the clinical significance of red cell alloantibodies based on Fc receptor-induced destruction of red cells sensitized by IgG. Transfusion 1994; 34: 617-626.
6. Van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH,. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. Acta Obstet Gynecol Scand 2004; 83: 731-737.
7. Smits-Wintjens VE, Walther FJ, Rath ME, Lindenburg IT, Te Pas AB, Kramer CM, Oepkes D, Brand A, Lopriore E,. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. Pediatrics 2011; 127: 680-686.
8. Smits-Wintjens VE, Rath ME, Lindenburg IT, Oepkes D, van, Zwet EW, Walther FJ, Lopriore E,. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome. Neonatology 2012; 101: 306-310.
9. Rath ME, Smits-Wintjens VE, Lindenburg I, Brand A, Oepkes D, Walther FJ, Lopriore E,. Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions. Vox Sang 2010; 99: 65-70.
10. Rath ME, Smits-Wintjens VE, Lindenburg IT, Brand A, Van Kamp IL, Oepkes D, Walther FJ, Lopriore E,. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease. Vox Sang 2011; 100: 312-316.
11. Rath ME, Smits-Wintjens VE, Oepkes D, van, Zwet EW, Van Kamp IL, Brand A, Walther FJ, Lopriore E,. Thrombocytopenia at birth in neonates with red cell alloimmune haemolytic disease. Vox Sang 2012; 102: 228-233.
12. Somerset DA, Moore A, Whittle MJ, Martin W, Kilby MD,. An audit of outcome in intravascular transfusions using the intrahepatic portion of the fetal umbilical vein compared to cordocentesis. Fetal Diagn Ther 2006; 21: 272-276.
13. Hackney DN, Knudtson EJ, Rossi KQ, Krugh D, O'Shaughnessy RW,. Management of pregnancies complicated by anti-c isoimmunization. Obstet Gynecol 2004; 103: 24-30.
14. Kozlowski CL, Lee D, Shwe KH, Love EM,. Quantification of anti-c in haemolytic disease of the newborn. Transfus Med 1995; 5: 37-42.
15. Koelewijn JM, Vrijkotte TG, van der, Schoot CE, Bonsel GJ, de, Haas M,. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 2008; 48: 941-952.
16. Roberts IAG,. Haematological values in the newborn. In:, Rennie JM, editor. Roberton's textbook of neonatology. 4th ed. Philadelphia: Elsevier; 2011. p. 1287.
17. Goodrum LA, Saade GR, Belfort MA, Carpenter RJ, Jr, Moise KJ, Jr,. The effect of intrauterine transfusion on fetal bilirubin in red cell alloimmunization. Obstet Gynecol 1997; 89: 57-60.
18. Dorn I, Schlenke P, Hartel C,. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro. Transfusion 2010; 50: 1064-1070.
19. van den Akker ES, de Haan TR, Lopriore E, Brand A, Kanhai HH, Oepkes D,. Severe fetal thrombocytopenia in rhesus D alloimmunized pregnancies. Am J Obstet Gynecol 2008; 199: 387.e1-3874.
20. Filbey D, Hanson U, Wesstrom G,. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. Acta Obstet Gynecol Scand 1995; 74: 687-692.
21. Gottvall T, Filbey D,. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden. Acta Obstet Gynecol Scand 2008; 87: 843-848.
22. Howard H, Martlew V, McFadyen I, Clarke C, Duguid J, Bromilow I, Eggington J,. Consequences for fetus and neonate of maternal red cell allo-immunisation. Arch Dis Child Fetal Neonatal Ed 1998; 78: F62-F66.
23. Karagol BS, Zenciroglu A, Okumus N, Karadag N, Dursun A, Hakan N,. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre. Am J Perinatol 2012; 29: 449-454.
24. Nordvall M, Dziegiel M, Hegaard HK, Bidstrup M, Jonsbo F, Christensen B, Hedegaard M,. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities. Transfusion 2009; 49: 2070-2075.